Trials / Not Yet Recruiting
Not Yet RecruitingNCT06645275
Point-of-Care Testing (POCT) for Guided Precision Anticoagulation With Warfarin: A Multicenter, Non-concurrent Controlled Study
- Status
- Not Yet Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 416 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare the key clinical indicators such as the time to achieve INR target, frequency of dose adjustment, and the incidence of thrombotic and hemorrhagic events between Point-of-Care Testing (POCT) and pyrosequencing technology in the precision dosing of warfarin, in order to assess whether POCT-based warfarin genetic testing is beneficial for improving the quality of anticoagulation treatment for patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | POCT test | Patients undergo POCT testing on the day of warfarin administration, and based on the POCT results, the initial and maintenance doses of warfarin are determined according to the IWPC algorithm. |
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2025-12-31
- Completion
- 2026-03-31
- First posted
- 2024-10-16
- Last updated
- 2024-10-16
Source: ClinicalTrials.gov record NCT06645275. Inclusion in this directory is not an endorsement.